Method for treating multiple sclerosis
AssigneeThe Kennedy Institute of Rheumatology
InventorsJohn Leslie Turk, David Baker, Marc Feldmann
Life of this patent
Estimating the term…
Abstract
A method for treating multiple sclerosis, through the administration of anti-tumour necrosis factor antibody, of soluble tumour necrosis factor receptor or of a compound capable of blocking tumour necrosis factor production, its effects and/or tumour necrosis factor receptor signal transduction, is disclosed. The method can be used to aid in therapy for humans and other mammals.
Claims15
A method of treating multiple sclerosis in a mammal, comprising administering to said mammal a therapeutically effective amount of a monoclonal anti-tumor necrosis factor alpha antibody which ameliorates the effects of multiple sclerosis, wherein said antibody is administered after onset of the multiple sclerosis.
A method of treating multiple sclerosis in a mammal, comprising administering to said mammal a therapeutically effective amount of a soluble tumor necrosis factor alpha receptor which ameliorates the effects of multiple sclerosis, wherein said receptor is administered after onset of the multiple sclerosis.
A method of treating multiple sclerosis in a human being, comprising administering directly to the central nervous system of said human being a therapeutically effective amount of an anti-tumor necrosis factor alpha antibody, wherein said antibody is administered after onset of the multiple sclerosis.
Dependencies are inferred from the claim text.